Apogee Therapeutics, Inc. - Common Stock, $0.00001 par value (APGE) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2023 to Q4 2025

Type / Class
Equity / Common Stock, $0.00001 par value
Symbol
APGE on Nasdaq
Shares outstanding
60,530,801
Price per share
$75.48
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
59,584,018
Total reported value
$2,367,665,565
% of total 13F portfolios
0%
Share change
+1,692,107
Value change
+$56,490,694
Number of holders
172
Price from insider filings
$75.48
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Apogee Therapeutics, Inc. - Common Stock, $0.00001 par value (APGE) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% $266,406,847 6,907,100 FMR LLC 30 Jun 2025
Fairmount Funds Management LLC 10% 0% $456,430,807 +$20,390,674 6,047,027 +4.7% Peter Evan Harwin 22 Jan 2026
WELLINGTON MANAGEMENT GROUP LLP 11% +29% $188,420,081 +$41,633,847 4,885,146 +28% Wellington Management Group LLP 31 Jul 2025
RTW INVESTMENTS, LP 6% $102,463,025 2,712,097 RTW Investments, LP 31 Dec 2024
BlackRock, Inc. 5.5% $109,396,539 2,518,725 BlackRock, Inc. 30 Jun 2025
DRIEHAUS CAPITAL MANAGEMENT LLC 4.7% $85,757,284 2,158,502 DRIEHAUS CAPITAL MANAGEMENT LLC 30 Sep 2025

As of 30 Sep 2025, 172 institutional investors reported holding 59,584,018 shares of Apogee Therapeutics, Inc. - Common Stock, $0.00001 par value (APGE). This represents 98% of the company’s total 60,530,801 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Apogee Therapeutics, Inc. - Common Stock, $0.00001 par value (APGE) together control 82% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VR ADVISER, LLC 14% 8,493,321 0% 19% $337,439,643
FMR LLC 11% 6,916,462 +0.14% 0.01% $274,791,036
WELLINGTON MANAGEMENT GROUP LLP 7.8% 4,723,701 +24% 0.03% $187,672,640
RTW INVESTMENTS, LP 4.5% 2,712,097 0% 1.3% $107,751,614
BlackRock, Inc. 4.4% 2,686,026 +4.8% 0% $106,715,814
VANGUARD GROUP INC 3.7% 2,245,631 +6.5% 0% $89,218,920
Driehaus Capital Management LLC 3.6% 2,158,502 -6.6% 0.61% $85,757,284
Fairmount Funds Management LLC 3.4% 2,048,647 0% 7.3% $81,392,745
STATE STREET CORP 2.7% 1,655,548 +31% 0% $65,774,922
Paradigm Biocapital Advisors LP 2.5% 1,521,757 +59% 1.8% $60,459,406
BRAIDWELL LP 2.4% 1,438,745 -2.7% 1.7% $57,161,339
ALLIANCEBERNSTEIN L.P. 2.3% 1,419,132 +2.2% 0.02% $56,382,114
PERCEPTIVE ADVISORS LLC 2.2% 1,351,989 +14% 1.6% $53,714,523
Affinity Asset Advisors, LLC 1.9% 1,173,426 +70% 4.3% $46,620,215
CITADEL ADVISORS LLC 1.9% 1,169,244 +136% 0.04% $46,454,065
JPMORGAN CHASE & CO 1.9% 1,137,731 +1.1% 0% $45,202,052
MERCER GLOBAL ADVISORS INC /ADV 1.6% 970,581 +18% 0.06% $38,561,183
GEODE CAPITAL MANAGEMENT, LLC 1.5% 892,203 +14% 0% $35,453,920
UBS Group AG 1.3% 799,465 +646% 0.01% $31,762,745
PRICE T ROWE ASSOCIATES INC /MD/ 1.2% 750,529 -1.4% 0% $29,820,000
FRANKLIN RESOURCES INC 1.2% 730,761 -14% 0.01% $29,033,130
BARCLAYS PLC 1.1% 642,316 +5.5% 0.01% $25,519,215
GOLDMAN SACHS GROUP INC 0.99% 599,616 -9% 0% $23,822,744
Jefferies Financial Group Inc. 0.94% 568,084 -12% 0.21% $22,569,977
Sofinnova Investments, Inc. 0.93% 565,417 +642% 1.4% $22,464,017

Institutional Holders of Apogee Therapeutics, Inc. - Common Stock, $0.00001 par value (APGE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 157,836 $11,915,276 -$2,440,979 $75.48 10
2025 Q3 59,584,018 $2,367,665,565 +$56,490,694 $39.73 172
2025 Q2 57,837,483 $2,511,890,310 -$147,322,983 $43.43 180
2025 Q1 61,488,037 $2,301,755,351 +$131,273,115 $37.36 165
2024 Q4 57,873,775 $2,621,627,227 +$63,332,544 $45.30 156
2024 Q3 56,092,373 $3,292,239,932 +$134,148,823 $58.74 137
2024 Q2 54,152,101 $2,130,892,019 -$9,800,456 $39.35 137
2024 Q1 52,915,146 $3,516,219,943 +$778,331,224 $66.45 137
2023 Q4 41,768,396 $1,163,676,392 +$48,111,524 $27.94 85
2023 Q3 40,111,211 $848,653,526 +$848,653,497 $21.30 73